首页> 外文期刊>Interdisciplinary Neurosurgery >Schwannoma response to interferon alpha
【24h】

Schwannoma response to interferon alpha

机译:Schwannoma对干扰素α的反应

获取原文
           

摘要

While cranial nerve schwannomas are typically benign, slow growing tumors, they are associated with morbidity both from the neuropathies and neuralgias they can produce, as well as from the treatments used to address these tumors, typically surgery or radiation. Here we present a case report of a patient with trigeminal neuralgia secondary to schwannoma where tumor regression is seen incidentally after patient received interferon alpha for his metastatic melanoma. Highlights ? A schwannoma resulting in trigeminal neuralgia is presented. ? Treatment with interferon alpha resulted in schwannoma regression. ? Interferon alpha should be investigated further in schwannomas.
机译:颅神经神经鞘瘤通常是良性的,生长缓慢的肿瘤,但与它们可能产生的神经病和神经痛以及用于解决这些肿瘤的治疗(通常是外科手术或放射治疗)的发病率相关。在这里,我们介绍一例继发于神经鞘瘤的三叉神经痛患者的病例报告,该患者因转移性黑素瘤接受干扰素α治疗后偶然看到肿瘤消退。强调 ?介绍了导致三叉神经痛的神经鞘瘤。 ?干扰素α治疗导致神经鞘瘤消退。 ?干扰素α应在神经鞘瘤中进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号